Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside

For investors parsing the latest analyst moves, Freshpet (NASDAQ:FRPT) presents a classic battleground: a price target cut that still screams upside. Wells Fargo’s trim to $70—down $5 but still 28% above the $54.51 stock price—arrives as shares languish below the 200-day moving average. Yet with a Moderate Buy consensus and an average target of $74.25, the $2.68 billion pet food maker embodies the tension between near-term headwinds and long-term growth potential that defines many high-beta consumer names in 2026’s uneven market.

Wells Fargo & Company (NYSE:WFC) trimmed its price target on Freshpet (NASDAQ:FRPT) from $75.00 to $70.00 on Wednesday, July 8, 2026, while maintaining an Overweight rating on the pet food maker. The revised target still implies a 28.42% upside from the stock’s previous close of $54.51, underscoring that the move is a modest recalibration rather than a bearish pivot. Freshpet, known for its refrigerated, fresh pet food category, has been a volatile growth story, with shares trading near the lower end of a 52-week range of $46.45 to $86.00. The cut comes amid a broader reevaluation by multiple research firms, reflecting a market environment where high-growth consumer staples are facing margin scrutiny and demand normalization post-pandemic.

“

However, the bullish camp has shown conviction: TD Cowen upgraded the stock to Buy with an $80.00 target in April, Oppenheimer lifted its rating to Outperform with an $80.00 target in March, and Morgan Stanley reiterated Overweight at $77.00 in May.

The analyst community remains largely constructive on FRPT despite a series of target reductions. Jefferies Financial Group and Bank of America both lowered their price objectives to $70.00, with Hold and Neutral ratings respectively, signaling caution. However, the bullish camp has shown conviction: TD Cowen upgraded the stock to Buy with an $80.00 target in April, Oppenheimer lifted its rating to Outperform with an $80.00 target in March, and Morgan Stanley reiterated Overweight at $77.00 in May. Even JPMorgan Chase upgraded from Neutral to Overweight, raising its target to $68.00. The net result is a consensus rating of Moderate Buy and an average price target of $74.25—36% above the current price—according to MarketBeat. This gap between market sentiment and analyst projections suggests that equity researchers see underlying value that the broader market has yet to acknowledge, possibly due to near-term earnings concerns or sector rotation.

Freshpet’s fundamentals present a mixed picture. The company’s financial health remains strong: a current ratio of 6.18 and a quick ratio of 5.26 indicate ample liquidity, while a debt-to-equity ratio of 0.34 points to conservative leverage. A price-to-earnings ratio of 14.57, relative to the pet food sector, is not demanding for a company with premium brand positioning and expanding distribution. Yet the stock’s beta of 1.60 underscores its volatility—shares have swung dramatically over the past year, and the technical picture is bearish. The stock currently trades below both its 50-day moving average of $53.84 and its 200-day moving average of $63.20, with the latter serving as overhead resistance. The decline from the $86.00 high represents a 36.6% drop, illustrating the market’s impatience with growth execution.